Risk of recurrent diabetic ketoacidosis following initiation of sodium‐glucose co‐transporter 2 inhibitors in patients with an insulin‐deficient diabetes and prior diabetic ketoacidosis: An observational cohort study

Documenti analoghi

• Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating SGLT2 inhibitors
  di: Anat Tsur, et al.
  Pubblicazione: (2025)
• Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis
  di: Anat Tsur, et al.
  Pubblicazione: (2025)
• Clinical characteristics and outcomes of diabetes‐related ketoacidosis ( DKA ) in sodium‐glucose co‐transporter‐2 inhibitor ( SGLT2i ) users with type 2 diabetes
  di: Angelica Sharma, et al.
  Pubblicazione: (2025)
• A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
  di: Carol Wysham, et al.
  Pubblicazione: (2025)
• Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
  di: Hsiao‐Ling Chen, et al.
  Pubblicazione: (2024)